Mankind Pharma, a leading domestic pharmaceutical and consumer health company, is all set to hit the market with a pure offer for sale (OFS) worth Rs 4,000 crore tomorrow, April 25. The IPO will conclude on April 27, 2023.
Recommended Articles
View All
Also Read: M&A Outlook 2023 — here's why pharma to be a promising sector for further investments this year
However the company's margins remained under pressure due to rise in in API prices, Juneja said.
Mankind Pharma, the fourth largest pharma company in terms of domestic sales, is the manufacturer of popular brands like Manforce, PregaNews, and Unwanted 72, which have gained immense popularity among consumers. The company's 98 percent sales are from India. Pharma accounts for 90 percent of the total sales, while consumer health accounts for 9-10 percent sales.
Tier 2-4 cities and rural account for 47 percent of sales, while 37 percent for industry. The company's key USP is affordability and accessibility. The products are priced 15-20 percent cheaper.
First Published: Apr 20, 2023 3:30 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
